4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-24-015543
SR. VP & CCO sold 46,844 shares at an average $33.72 ($1,579,353)
- SR. VP & CCO acquired 67,469 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Option exercise | +20,625 | $2.78 | $57,338 | 20,833 | D |
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Option exercise | +28,469 | $28.00 | $797,132 | 49,302 | D |
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Option exercise | +18,375 | $22.48 | $413,070 | 67,677 | D |
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Sale | −27,580 | $33.53 | $924,658 | 40,097 | D |
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Sale | −19,264 | $33.99 | $654,695 | 20,833 | D |
| Derivatives | |||||||
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Option exercise · Incentive Stock Option (right to buy) | −20,625 | 0 | D | ||
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Option exercise · Incentive Stock Option (right to buy) | −28,469 | 13,531 | D | ||
| Wright Richard M. SR. VP & CCO | 2024-06-03 | Option exercise · Incentive Stock Option (right to buy) | −18,375 | 23,625 | D | ||
| Open-market sales · 46,844 sh · avg $33.72 · $1,579,353 | |||||||
Loading xslF345X05/form4-06052024_080641.xml…